Mychal James Bradley Gibbens

Array ( [id] => 10248367 [patent_doc_number] => 20150133364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'DIPEPTOID PRODRUGS AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 14/598902 [patent_app_country] => US [patent_app_date] => 2015-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20465 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14598902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10468586 [patent_doc_number] => 20150353602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY' [patent_app_type] => utility [patent_app_number] => 14/598036 [patent_app_country] => US [patent_app_date] => 2015-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 26070 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14598036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12198573 [patent_doc_number] => 09901622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-27 [patent_title] => 'Rapid action insulin formulations and pharmaceutical delivery systems' [patent_app_type] => utility [patent_app_number] => 15/110758 [patent_app_country] => US [patent_app_date] => 2015-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 28 [patent_no_of_words] => 19006 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11604066 [patent_doc_number] => 20170121366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-04 [patent_title] => 'DIPEPTIDES AS INHIBITORS OF HUMAN IMMUNOPROTEASOMES' [patent_app_type] => utility [patent_app_number] => 15/110000 [patent_app_country] => US [patent_app_date] => 2015-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 50175 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11443216 [patent_doc_number] => 20170044236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'Integrin Antagonists' [patent_app_type] => utility [patent_app_number] => 15/109602 [patent_app_country] => US [patent_app_date] => 2015-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 33611 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15109602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10289210 [patent_doc_number] => 20150174207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'METHODS FOR TREATING CANCER WITH GHRH AGONISTS' [patent_app_type] => utility [patent_app_number] => 14/582866 [patent_app_country] => US [patent_app_date] => 2014-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 27170 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14582866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13116479 [patent_doc_number] => 10076575 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-18 [patent_title] => Peptide, complex of peptide and siRNA and use thereof [patent_app_type] => utility [patent_app_number] => 15/106108 [patent_app_country] => US [patent_app_date] => 2014-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 6478 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15106108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12962626 [patent_doc_number] => 09873724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-23 [patent_title] => Pro-angiogenic peptides and peptide conjugates [patent_app_type] => utility [patent_app_number] => 15/105762 [patent_app_country] => US [patent_app_date] => 2014-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 14646 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12448548 [patent_doc_number] => 09982035 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-29 [patent_title] => Modified serpins for the treatment of bleeding disorders [patent_app_type] => utility [patent_app_number] => 15/103420 [patent_app_country] => US [patent_app_date] => 2014-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 23944 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15103420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10230157 [patent_doc_number] => 20150115150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-30 [patent_title] => 'KISSPEPTIN-54 DETECTION BY TANDEM MASS SPECTROMETRY' [patent_app_type] => utility [patent_app_number] => 14/565805 [patent_app_country] => US [patent_app_date] => 2014-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12449 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14565805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12997613 [patent_doc_number] => 10022453 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-17 [patent_title] => Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP) [patent_app_type] => utility [patent_app_number] => 15/105486 [patent_app_country] => US [patent_app_date] => 2014-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 142642 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11127973 [patent_doc_number] => 20160324947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-10 [patent_title] => 'PROLINE-RICH PEPTIDES PROTECTIVE AGAINST S. PNEUMONIAE' [patent_app_type] => utility [patent_app_number] => 15/101214 [patent_app_country] => US [patent_app_date] => 2014-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16119 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15101214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11429061 [patent_doc_number] => 09567368 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-14 [patent_title] => 'Peptide tyrosinase activators' [patent_app_type] => utility [patent_app_number] => 14/555316 [patent_app_country] => US [patent_app_date] => 2014-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 14438 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14555316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11324962 [patent_doc_number] => 20160355575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-08 [patent_title] => 'OLIGOPEPTIDE AND METHODS FOR PRODUCING CONJUGATES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/035602 [patent_app_country] => US [patent_app_date] => 2014-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 23560 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14119301 [patent_doc_number] => 10246497 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-02 [patent_title] => Selective PYY compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 15/036201 [patent_app_country] => US [patent_app_date] => 2014-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21444 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13237021 [patent_doc_number] => 10131702 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-20 [patent_title] => Glucagon-GLP-1-GIP triple agonist compounds [patent_app_type] => utility [patent_app_number] => 15/034784 [patent_app_country] => US [patent_app_date] => 2014-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11530 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15034784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13154003 [patent_doc_number] => 10093713 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-09 [patent_title] => GIP-GLP-1 dual agonist compounds and methods [patent_app_type] => utility [patent_app_number] => 15/034778 [patent_app_country] => US [patent_app_date] => 2014-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 14823 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15034778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10150128 [patent_doc_number] => 09182410 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-11-10 [patent_title] => 'Quantification of misfolded TNFR2:Fc' [patent_app_type] => utility [patent_app_number] => 14/516992 [patent_app_country] => US [patent_app_date] => 2014-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 13312 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14516992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11197280 [patent_doc_number] => 09427475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-30 [patent_title] => 'Glucose-responsive insulin conjugates' [patent_app_type] => utility [patent_app_number] => 14/504476 [patent_app_country] => US [patent_app_date] => 2014-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 87392 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14504476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10266004 [patent_doc_number] => 20150151002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'TARGETED THERAPY FOR THE PREVENTION OF RESTENOSIS IN THE CARDIOVASCULAR SYSTEM' [patent_app_type] => utility [patent_app_number] => 14/502252 [patent_app_country] => US [patent_app_date] => 2014-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 12348 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14502252 [rel_patent_id] =>[rel_patent_doc_number] =>)